Discontinuation/Dose Reduction of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers during Acute Decompensated Heart Failure in African-American Patients with Reduced Left-Ventricular Ejection Fraction
The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
Objectives: Patients with heart failure (HF) and reduced left-ventricular ejection fraction (LVEF) benefit from angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blocker (ARB) therapy. While dose reduction/discontinuation (r/d) of β-blockers (BB) and furosemide in acute decompensated HF (ADHF) worsen outcomes, data on ACEI/ARB are lacking. Methods: To determine the frequency and reasons for ACEI/ARB therapy r/d in ADHF patients, we studied 174 patients with LVEF <40% on ACEI/ARB and BB therapy upon admission over 1 year. Results: ACEI/ARB doses were r/d in 17.2% because of acute kidney injury (56.7%), hypotension (23.3%), and hyperkalemia (10%). Clinical characteristics were similar between patients with r/d and continued therapy. Admission and discharge creatinine (Cr) levels were higher in the r/d group. On multivariate analysis, admission Cr and admission systolic blood pressures were independent predictors of r/d. Among patients with renal dysfunction cited as the r/d reason, Cr did not significantly rise in 23.5%. The r/d group had a longer length of stay (LOS). Conclusions: ACEI/ARB dose is reduced and/or discontinued in nearly one-fifth of all ADHF admissions, and LOS is longer in the ACEI/ARB r/d group. While impaired renal function is the most frequently cited reason, nearly one-fourth of the patients had stable renal function. ACEI/ARB r/d therapy in the setting of ADHF merits further study.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One analysis showed that ACEI/ARB medications were reduced or discontinued because of acute kidney injury (57%), hypotension (23%), and hyperkalemia (10%); serum creatinine and systolic at admission were significant independent predictors of in-hospital dose reduction or discontinuation.17”
From CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction (2021) · cites this paper as [17]
In the citing paper
“Although renal dysfunction was noted as the most common cause for reduction of ACEI/ARB therapy, 24% of patients had no significant in-hospital rise in creatinine level, and medication changes were made in anticipation of deteriorating renal function rather than documented change in renal function.17”
From CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction (2021) · cites this paper as [17]
Citations
Cites
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,121
Swedberg, K., & Kjekshus, J. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
McMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,106
Garg, R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520420066040 · Cited by 1,771
Granger, C. B., McMurray, J. J., Yusuf, S., Held, P., Michelson, E. L., Olofsson, B., Östergren, J., Pfeffer, M. A., & Swedberg, K. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14284-5 · Cited by 1,686
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Acute Kidney Injury
Palevsky, P. M., Liu, K. D., Brophy, P. D., Chawla, L. S., Parikh, C. R., Thakar, C. V., Tolwani, A. J., Waikar, S. S., & Weisbord, S. D. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.02.349 · Cited by 935
Renal Impairment and Outcomes in Heart Failure
Smith, G. L., Lichtman, J. H., Bracken, M. B., Shlipak, M. G., Phillips, C. O., DiCapua, P., & Krumholz, H. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.084 · Cited by 897
Heywood, J. T., Fonarow, G. C., Costanzo, M. R., Mathur, V. S., Wigneswaran, J. R., & Wynne, J. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.03.011 · Cited by 786
Exner, D. V., Dries, D. L., Domanski, M. J., & Cohn, J. N. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441802 · Cited by 567
Garrick, R. (2008) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)79141-7 · Cited by 556
Recent National Trends in Readmission Rates After Heart Failure Hospitalization
Ross, J. S., Chen, J., Lin, Z., Bueno, H., Curtis, J. P., Keenan, P. S., Normand, S.-L. T., Schreiner, G., Spertus, J. A., Vidán, M. T., et al. (2010) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.885210 · Cited by 450
Swedberg, K. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1098 · Cited by 208
Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure
Prins, K. W., Neill, J. M., Tyler, J. O., Eckman, P. M., & Duval, S. (2015) · JACC: Heart Failure · doi:10.1016/j.jchf.2015.03.008 · Cited by 190
Roy, A. K., Mc Gorrian, C., Treacy, C., Kavanaugh, E., Brennan, A., Mahon, N. G., & Murray, P. T. (2013) · Cardiorenal Medicine · doi:10.1159/000347037 · Cited by 164
Rouleau, J. L., Roecker, E. B., Tendera, M., Mohaçsi, P., Krum, H., Katus, H. A., Fowler, M. B., Coats, A. J. S., Castaigne, A., Scherhag, A. W., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.037 · Cited by 163
Renin-Angiotensin Inhibition in Systolic Heart Failure and Chronic Kidney Disease
Ahmed, A., Fonarow, G. C., Zhang, Y., Sanders, P. W., Allman, R. M., Arnett, D. K., Feller, M. A., Love, T. E., Aban, I. B., Levesque, R., et al. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.10.013 · Cited by 78
Ivers, N. M., Schwalm, J.-D., Jackevicius, C. A., Guo, H., Tu, J. V., & Natarajan, M. K. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.04.009 · Cited by 51
Ahmed, A., Centor, R. M., Weaver, M. T., & Perry, G. J. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.06.030 · Cited by 44
Outcome in Acute Heart Failure: Prognostic Value of Acute Kidney Injury and Worsening Renal Function
Berra, G., Garin, N., Stirnemann, J., Jannot, A., Martin, P., Perrier, A., & Carballo, S. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.12.015 · Cited by 36
Worsening renal function in heart failure: The need for a consensus definition
Sheerin, N., Newton, P. J., Macdonald, P. S., Leung, D. Y., Sibbritt, D. W., Spicer, S. T., Johnson, K., Krum, H., & Davidson, P. M. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.162 · Cited by 33
New medications for heart failure
Gordin, J. S., & Fonarow, G. C. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.02.008 · Cited by 32
A Prescription at Discharge Improves Long-term Adherence for Secondary Stroke Prevention
Tsai, J. P.-C., Rochon, P. A., Raptis, S., Bronskill, S. E., Bell, C. M., & Saposnik, G. (2014) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2014.04.026 · Cited by 22
El-Refai, M., Hrobowski, T. N., Peterson, E. L., Wells, K. E., Spertus, J. A., Williams, L. K., & Lanfear, D. E. (2014) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000091 · Cited by 13
Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure
Woodruff, A. E., Kelley, A. M., Hempel, C., Loeffler, W., Echtenkamp, C. A., & Hassan, A. K. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016637385 · Cited by 9
Cited by
McDonald, M., Virani, S., Chan, M., Ducharme, A., Ezekowitz, J. A., Giannetti, N., Heckman, G. A., Howlett, J. G., Koshman, S. L., Lepage, S., et al. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.01.017 · Cited by 287
“Although renal dysfunction was noted as the most common cause for reduction of ACEI/ARB therapy, 24% of patients had no significant in-hospital rise in creatinine level, and medication changes were made in anticipation of deteriorating renal function rather than documented change in renal function.(17) A matched-cohor…”
BackgroundResultBhagat, A. A., Greene, S. J., Vaduganathan, M., Fonarow, G. C., & Butler, J. (2019) · JACC: Heart Failure · doi:10.1016/j.jchf.2018.06.011 · Cited by 169
“Another analysis among African American patients found that ACEI/ARB medications were reduced or discontinued because of acute kidney injury (57%), hypotension (23%), and hyperkalemia (10%); serum creatinine and systolic blood pressure at admission were significant independent predictors of in-hospital dose reduction…”
BackgroundInfluentialInsani, W. N., Whittlesea, C., Alwafi, H. H., Man, K. K. C., Chapman, S., & Wei, L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252161 · Cited by 161
Srivastava, P. K., DeVore, A. D., Hellkamp, A. S., Thomas, L., Albert, N. M., Butler, J., Patterson, J. H., Spertus, J. A., Williams, F. B., Duffy, C. I., et al. (2021) · JACC: Heart Failure · doi:10.1016/j.jchf.2020.08.017 · Cited by 71
Oliveros, E., Oni, E., Shahzad, A., Kluger, A. Y., Lo, K. B., Rangaswami, J., & McCullough, P. A. (2020) · Cardiorenal Medicine · doi:10.1159/000504167 · Cited by 30
Metadata
- Authors
- Kane, J. A., Kim, J. K., Haidry, S. A., Salciccioli, L., & Lazar, J.
- Affiliations
- SUNY Downstate Health Sciences University (US)
- Venue
- Cardiology
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 137
- Issue
- 2
- Pages
- 121-125
- ISSN
- 0008-6312 (ISSN-L)
- 1421-9751
- OpenAlex
- W2604463073
- Cited by
- 30
- References
- 28
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 4 · 2020: 9 · 2019: 5 · 2018: 1
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Keywords
- ACE inhibitors, angiotensin receptor blockers, acute decompensated heart failure, reduced left ventricular ejection fraction, African American patients, acute kidney injury, hypotension, hyperkalemia, renal dysfunction, length of hospital stay, systolic blood pressure
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Angiotensin-Converting Enzyme Inhibitors, Black or African American, Creatinine, Dose-Response Relationship, Drug, Female, Heart Failure, Hospitalization, Humans, Hyperkalemia, Hypotension, Male, Middle Aged, Retrospective Studies, Stroke Volume, United States, Multivariate Analysis, Ventricular Function, Left, Angiotensin Receptor Antagonists, Acute Kidney Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.